The role of DNA damage response pathways in chromosome fragility in Fragile X syndrome

Nucleic Acids Research

Volumn 37, Issue 13, 2009, Pages 4385-4392

  Kumari, Daman ^a   Somma, Valentina ^b   Nakamura, Asako J ^c   Bonner, William M ^c   D'Ambrosio, Ettoré ^b   Usdin, Karen ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b CNR   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; APC PROTEIN; APHIDICOLIN; ATM PROTEIN; ATR PROTEIN; ETOPOSIDE; FLOXURIDINE; FRAGILE X MENTAL RETARDATION PROTEIN; HISTONE H2AX; HYDROXYUREA; PROTEIN FRAXA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITE; CHROMOSOME FRAGILITY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND; FRAGILE X SYNDROME; GENE DELETION; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENE LOCUS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

APHIDICOLIN; CELL CYCLE PROTEINS; CELL LINE; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FLOXURIDINE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE KNOCKDOWN TECHNIQUES; HISTONES; HUMANS; MALE; MORPHOLINES; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PYRONES; STAUROSPORINE; TUMOR SUPPRESSOR PROTEINS;

EID: 68049132876     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp391     Document Type: Article

References (54)

1. Howard-Peebles,P.N. and Stoddard,G.R. (1979) X-linked mental retardation with macro-orchidism and marker X chromosomes. Hum. Genet., 50 247-251.
2. Sutherland,G.R. and Ashforth,P.L. (1979) X-linked mental retardation with macro-orchidism and the fragile site at Xq 27 or 28. Hum. Genet. 48, 117-120.
3. Fu,Y.H., Kuhl,D.P., Pizzuti,A., Pieretti,M., Sutcliffe,J.S., Richards,S., Verkerk,A.J., Holden,J.J., Fenwick,R.G. Jr, Warren,S.T. et al. (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell, 67, 1047-1058.
4. Verkerk,A.J., Pieretti,M., Sutcliffe,J.S., Fu,Y.H., Kuhl,D.P., Pizzuti,A., Reiner,O., Richards,S., Victoria,M.F., Zhang,F.P. et al. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905-914.
5. Debacker,K., Winnepenninckx,B., Longman,C., Colgan,J., Tolmie,J., Murray,R., van Luijk,R., Scheers,S., Fitzpatrick,D. and Kooy,F. (2007) The molecular basis of the folate-sensitive fragile site FRA11A at 11q13. Cytogenet Genome Res., 119, 9-14.
6. Gecz,J., Gedeon,A.K., Sutherland,G.R. and Mulley,J.C. (1996) Identification of the gene FMR2, associated with FRAXE mental retardation. Nat. Genet., 13, 105-108.
7. Gu,Y., Shen,Y., Gibbs,R.A. and Nelson,D.L. (1996) Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat. Genet., 13, 109-113.
8. Parrish,J.E., Oostra,B.A., Verkerk,A.J., Richards,C.S., Reynolds,J., Spikes,A.S., Shaffer,L.G. and Nelson,D.L. (1994) Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat. Genet., 8, 229-235.
9. Sarafidou,T., Kahl,C., Martinez-Garay,I., Mangelsdorf,M., Gesk,S., Baker,E., Kokkinaki,M., Talley,P., Maltby,E.L., French,L. et al. (2004) Folate-sensitive fragile site FRA10A is due to an expansion of a CGG repeat in a novel gene, FRA10AC1, encoding a nuclear protein. Genomics, 84, 69-81.
10. Winnepenninckx,B., Debacker,K., Ramsay,J., Smeets,D., Smits,A., FitzPatrick,D.R. and Kooy,R.F. (2007) CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1. Am. J. Hum. Genet., 80, 221-231.
11. Warren,S.T., Knight,S.J., Peters,J.F., Stayton,C.L., Consalez,G.G. and Zhang,F.P. (1990) Isolation of the human chromosomal band Xq28 within somatic cell hybrids by fragile X site breakage. Proc. Natl Acad. Sci. USA, 87, 3856-3860.
12. Jones,C., Penny,L., Mattina,T., Yu,S., Baker,E., Voullaire,L., Langdon,W.Y., Sutherland,G.R., Richards,R.I. and Tunnacliffe,A. (1995) Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature, 376, 145-149.
13. Jones,C., Slijepcevic,P., Marsh,S., Baker,E., Langdon,W.Y., Richards,R.I. and Tunnacliffe,A. (1994) Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum. Mol. Genet., 3, 2123-2130.
14. Callahan,G., Denison,S.R., Phillips,L.A., Shridhar,V. and Smith,D.I. (2003) Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene, 22, 590-601.
15. Curatolo,A., Limongi,Z.M., Pelliccia,F. and Rocchi,A. (2007) Molecular characterization of the human common fragile site FRA1H. Genes Chromosomes Cancer, 46, 487-493.
16. Denison,S.R., Callahan,G., Becker,N.A., Phillips,L.A. and Smith,D.I. (2003) Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosomes Cancer, 38, 40-52.
17. Huang,H., Qian,J., Proffit,J., Wilber,K., Jenkins,R. and Smith,D.I. (1998) FRA7G extends over a broad region: Coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites. Oncogene, 16, 2311-2319.
18. Mangelsdorf,M., Ried,K., Woollatt,E., Dayan,S., Eyre,H., Finnis,M., Hobson,L., Nancarrow,J., Venter,D., Baker,E. et al. (2000) Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res., 60, 1683-1689.
19. Mishmar,D., Rahat,A., Scherer,S.W., Nyakatura,G., Hinzmann,B., Kohwi,Y., Mandel-Gutfroind,Y., Lee,J.R., Drescher,B., Sas,D.E. et al. (1998) Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc. Natl Acad. Sci. USA, 95, 8141-8146.
20. Paradee,W., Wilke,C.M., Wang,L., Shridhar,R., Mullins,C.M., Hoge,A., Glover,T.W. and Smith,D.I. (1996) A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints. Genomics, 35, 87-93.
21. Rassool,F.V., Le Beau,M.M., Shen,M.L., Neilly,M.E., Espinosa,R. 3rd, Ong,S.T., Boldog,F., Drabkin,H., McCarroll,R. and McKeithan,T.W. (1996) Direct cloning of DNA sequences from the common fragile site region at chromosome band 3p14.2. Genomics, 35, 109-117.
22. Rozier,L., El-Achkar,E., Apiou,F. and Debatisse,M. (2004) Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: Possible association with an inherited disease and cancer. Oncogene, 23, 6872-6880.
23. Sawinska,M., Schmitt,J.G., Sagulenko,E., Westermann,F., Schwab,M. and Savelyeva,L. (2007) Novel aphidicolin-inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene. Genes Chromosomes Cancer, 46, 991-999.
24. Helmrich,A., Stout-Weider,K., Matthaei,A., Hermann,K., Heiden,T. and Schrock,E. (2007) Identification of the human/mouse syntenic common fragile site FRA7K/Fra12C1 - relation of FRA7K and other human common fragile sites on chromosome 7 to evolutionary breakpoints. Int. J. Cancer, 120, 48-54.
25. Limongi,M.Z., Pelliccia,F. and Rocchi,A. (2003) Characterization of the human common fragile site FRA2G. Genomics, 81, 93-97.
26. Morelli,C., Karayianni,E., Magnanini,C., Mungall,A.J., Thorland,E., Negrini,M., Smith,D.I. and Barbanti-Brodano,G. (2002) Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene, 21, 7266-7276.
27. Ried,K., Finnis,M., Hobson,L., Mangelsdorf,M., Dayan,S., Nancarrow,J.K., Woollatt,E., Kremmidiotis,G., Gardner,A., Venter,D. et al. (2000) Common chromosomal fragile site FRA16D sequence: Identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum. Mol. Genet., 9, 1651-1663.
28. Corbin,S., Neilly,M.E., Espinosa,R. 3rd, Davis,E.M., McKeithan,T.W. and Le Beau,M.M. (2002) Identification of unstable sequences within the common fragile site at 3p14.2: Implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. Cancer Res., 62, 3477-3484.
29. Cheng,C.H. and Kuchta,R.D. (1993) DNA polymerase epsilon: Aphidicolin inhibition and the relationship between polymerase and exonuclease activity. Biochemistry, 32, 8568-8574.
30. Ikegami,S., Taguchi,T., Ohashi,M., Oguro,M., Nagano,H. and Mano,Y. (1978) Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha. Nature, 275, 458-460.
31. Hurley,P.J. and Bunz,F. (2007) ATM and ATR: Components of an integrated circuit. Cell Cycle, 6, 414-417.
32. Yang,J., Xu,Z.P., Huang,Y., Hamrick,H.E., Duerksen-Hughes,P.J. and Yu,Y.N. (2004) ATM and ATR: Sensing DNA damage. World J. Gastroenterol., 10, 155-160.
33. Arlt,M.F., Xu,B., Durkin,S.G., Casper,A.M., Kastan,M.B. and Glover,T.W. (2004) BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function. Mol. Cell Biol., 24, 6701-6709.
34. Casper,A.M., Nghiem,P., Arlt,M.F. and Glover,T.W. (2002) ATR regulates fragile site stability. Cell, 111, 779-789.
35. Durkin,S.G., Arlt,M.F., Howlett,N.G. and Glover,T.W. (2006) Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites. Oncogene, 25, 4381-4388.
36. Howlett,N.G., Taniguchi,T., Durkin,S.G., D'Andrea,A.D. and Glover,T.W. (2005) The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum. Mol. Genet., 14, 693-701.
37. Ozeri-Galai,E., Schwartz,M., Rahat,A. and Kerem,B. (2008) Interplay between ATM and ATR in the regulation of common fragile site stability. Oncogene, 27, 2109-2117.
38. Schwartz,M., Zlotorynski,E., Goldberg,M., Ozeri,E., Rahat,A., le Sage,C., Chen,B.P., Chen,D.J., Agami,R. and Kerem,B. (2005) Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes Dev., 19, 2715-2726.
39. Gray,S.J., Gerhardt,J., Doerfler,W., Small,L.E. and Fanning,E. (2007) An origin of DNA replication in the promoter region of the human fragile X mental retardation (FMR1) gene. Mol. Cell Biol., 27, 426-437.
40. Petersen,S., Casellas,R., Reina-San-Martin,B., Chen,H.T., Difilippantonio,M.J., Wilson,P.C., Hanitsch,L., Celeste,A., Muramatsu,M., Pilch,D.R. et al. (2001) AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature, 414, 660-665.
41. Bonner,W.M., Redon,C.E., Dickey,J.S., Nakamura,A.J., Sedelnikova,O.A., Solier,S. and Pommier,Y. (2008) GammaH2AX and cancer. Nat. Rev. Cancer, 8, 957-967.
42. McClintock,B. (1938) The production of homozygous deficient tissues with mutant characteristics by means of the aberrant mitotic behavior of ring-shaped chromosomes. Genetics, 23, 315-376.
43. Ciullo,M., Debily,M.A., Rozier,L., Autiero,M., Billault,A., Mayau,V., El Marhomy,S., Guardiola,J., Bernheim,A., Coullin,P. et al. (2002) Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: The model of PIP gene duplication from a break at FRA7I. Hum. Mol. Genet., 11 2887-2894.
44. Hellman,A., Zlotorynski,E., Scherer,S.W., Cheung,J., Vincent,J.B., Smith,D.I., Trakhtenbrot,L. and Kerem,B. (2002) A role for common fragile site induction in amplification of human oncogenes. Cancer Cell, 1, 89-97.
45. Hickson,I., Zhao,Y., Richardson,C.J., Green,S.J., Martin,N.M., Orr,A.I., Reaper,P.M., Jackson,S.P., Curtin,N.J. and Smith,G.C. (2004) Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res., 64 9152-9159.
46. Bolderson,E., Scorah,J., Helleday,T., Smythe,C. and Meuth,M. (2004) ATM is required for the cellular response to thymidine induced replication fork stress. Hum. Mol. Genet., 13, 2937-2945.
47. Howard-Peebles,P.N., Stoddard,G.R. and Mims,M.G. (1979) Familial X-linked mental retardation, verbal disability, and marker X chromosomes. Am. J. Hum. Genet., 31, 214-222.
48. Ledbetter,S.A. and Ledbetter,D.H. (1988) A common fragile site at Xq27: theoretical and practical implications. Am. J. Hum. Genet., 42 694-702.
49. Liu,X., Matsuda,A. and Plunkett,W. (2008) Ataxia-telangiectasia and Rad3-related and DNA-dependent protein kinase cooperate in G2 checkpoint activation by the DNA strand-breaking nucleoside analogue 2′-C-cyano-2′-deoxy-1-beta-D-arabino-pentofuranosylcytosine. Mol. Cancer Ther., 7, 133-142.
50. Usdin,K. and Woodford,K.J. (1995) CGG repeats associated with DNA instability and chromosome fragility form structures that block DNA synthesis in vitro. Nucleic Acids Res., 23, 4202-4209.
51. Samadashwily,G.M., Raca,G. and Mirkin,S.M. (1997) Trinucleotide repeats affect DNA replication in vivo. Nat. Genet., 17, 298-304.
52. Pelletier,R., Krasilnikova,M.M., Samadashwily,G.M., Lahue,R. and Mirkin,S.M. (2003) Replication and expansion of trinucleotide repeats in yeast. Mol. Cell Biol., 23, 1349-1357.
53. Entezam,A. and Usdin,K. (2008) ATR protects the genome against CGG.CCG-repeat expansion in Fragile X premutation mice. Nucleic Acids Res., 36, 1050-1056.
54. Dyer,K.A., Canfield,T.K. and Gartler,S.M. (1989) Molecular cytological differentiation of active from inactive X domains in interphase: implications for X chromosome inactivation. Cytogenet. Cell Genet. 50, 116-120.